中国妇幼健康研究
中國婦幼健康研究
중국부유건강연구
CHINESE JOURNAL OF MATERNAL AND CHILD HEALTH RESEARCH
2014年
5期
888-890
,共3页
宫颈腺癌%早期%治疗%预后
宮頸腺癌%早期%治療%預後
궁경선암%조기%치료%예후
cervical adenocacinoma%early stage%treatment%prognosis
目的:探讨宫颈腺癌早期手术治疗、预后及影响因素。方法选择浙江省肿瘤医院2002年1月至2008年12月间收治的58例宫颈腺癌患者为研究对象,回顾分析所有患者临床及病理资料。结果患者总体5年生存率为74.14%,Ⅰ期患者生存率为87.50%,Ⅱ期患者生存率为57.69%。单因素分析显示肿瘤直径、临床分期、组织学类型和盆腔淋巴结转移与宫颈腺癌5年总生存率相关,差异具有统计学意义(χ2值分别为7.96、6.65、9.35、13.14,均P<0.05)。结论影响宫颈腺癌预后的主要因素为肿瘤直径、临床分期、组织学类型和盆腔淋巴结转移,根治性手术对早期宫颈腺癌,特别是Ⅰ期治疗效果显著。
目的:探討宮頸腺癌早期手術治療、預後及影響因素。方法選擇浙江省腫瘤醫院2002年1月至2008年12月間收治的58例宮頸腺癌患者為研究對象,迴顧分析所有患者臨床及病理資料。結果患者總體5年生存率為74.14%,Ⅰ期患者生存率為87.50%,Ⅱ期患者生存率為57.69%。單因素分析顯示腫瘤直徑、臨床分期、組織學類型和盆腔淋巴結轉移與宮頸腺癌5年總生存率相關,差異具有統計學意義(χ2值分彆為7.96、6.65、9.35、13.14,均P<0.05)。結論影響宮頸腺癌預後的主要因素為腫瘤直徑、臨床分期、組織學類型和盆腔淋巴結轉移,根治性手術對早期宮頸腺癌,特彆是Ⅰ期治療效果顯著。
목적:탐토궁경선암조기수술치료、예후급영향인소。방법선택절강성종류의원2002년1월지2008년12월간수치적58례궁경선암환자위연구대상,회고분석소유환자림상급병리자료。결과환자총체5년생존솔위74.14%,Ⅰ기환자생존솔위87.50%,Ⅱ기환자생존솔위57.69%。단인소분석현시종류직경、림상분기、조직학류형화분강림파결전이여궁경선암5년총생존솔상관,차이구유통계학의의(χ2치분별위7.96、6.65、9.35、13.14,균P<0.05)。결론영향궁경선암예후적주요인소위종류직경、림상분기、조직학류형화분강림파결전이,근치성수술대조기궁경선암,특별시Ⅰ기치료효과현저。
Objective To evaluate the surgical treatment, prognosis and influencing factors of early-stage cervical adenocacinoma. Methods Retrospective analysis was conducted on the clinical and pathological records of 58 patients with cervical adnenocarcinoma treated in Cancer Hospital of Zhejiang Province during the period of January 2002 to December 2008.Results The overall 5-year survival rate of all patients was 74.14%.The 5-year survival rate of patients with stageⅠand stage Ⅱ was 87.50% and 57.69%, respectively.Univariate analysis showed that tumor size, clinical stage, histopathological type and pelvic lymph node metastasis were the main prognostic factors affecting 5-year survival rate, and there was significant difference (χ2 value was 7.96, 6.65, 9.35 and 13.14, respectively, all P<0.05). Conclusion The major influencing factors of prognosis of cervical adenocarcinoma include tumor size, clinical stage, histopathological type and pelvic lymph node metastasis.Radical hysterectomy is an effective treatment for patients with early-stage cervical adenocacinoma, especially for stage I disease.